This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.04.095v1 50/12/1150    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Buxton, A. E. Search for Related Content PubMed Articles by Buxton, A. E. Related Collections Related Article

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease

Lessons From the MUSTT Study

Alfred E. Buxton, MD, FACC^_*,_*, Kerry L. Lee, PhD, Gail E. Hafley, MS, Luis A. Pires, MD, John D. Fisher, MD, Michael R. Gold, MD^||, Mark E. Josephson, MD^#, Michael H. Lehmann, MD^_**, Eric N. Prystowsky, MD for the MUSTT Investigators

^_* Department of Medicine, Cardiology Division, Brown Medical School and Lifespan Academic Medical Center, Providence, Rhode Island
Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina
St. John Hospital and Medical Center and Wayne State University School of Medicine, Detroit, Michigan
Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York
^|| Medical University of South Carolina, Charleston, South Carolina
^# Beth Israel Deaconess Medical Center, Boston, Massachusetts
^_** Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
Care Group, Indianapolis, Indiana.

Manuscript received January 23, 2007; revised manuscript received April 17, 2007, accepted April 23, 2007.

^_* Reprint requests and correspondence: Dr. Alfred E. Buxton, Cardiology Division, Brown Medical School, 2 Dudley Street, Suite 360, Providence, Rhode Island 02905. (Email: alfred_buxton{at}brown.edu).

Objectives: We determined the contribution of multiple variables to predict arrhythmic death and total mortality risk in patients with coronary disease and left ventricular dysfunction. We then constructed an algorithm to predict risk of mortality and sudden death.

Background: Many factors in addition to ejection fraction (EF) influence the prognosis of patients with coronary disease. However, there are few tools to use this information to guide clinical decisions.

Methods: We evaluated the relationship between 25 variables and total mortality and arrhythmic death in 674 patients enrolled in the MUSTT (Multicenter Unsustained Tachycardia Trial) study that did not receive antiarrhythmic therapy. We then constructed risk-stratification algorithms to weight the prognostic impact of each variable on arrhythmic death and total mortality risk.

Results: The variables having the greatest prognostic impact in multivariable analysis were functional class, history of heart failure, nonsustained ventricular tachycardia not related to bypass surgery, EF, age, left ventricular conduction abnormalities, inducible sustained ventricular tachycardia, enrollment as an inpatient, and atrial fibrillation. The model demonstrates that patients whose only risk factor is EF 30% have a predicted 2-year arrhythmic death risk <5%.

Conclusions: Multiple variables influence arrhythmic death and total mortality risk. Patients with EF 30% but no other risk factor have low predicted mortality risk. Patients with EF >30% and other risk factors may have higher mortality and a higher risk of sudden death than some patients with EF 30%. Thus, risk of sudden death in patients with coronary disease depends on multiple variables in addition to EF.

Abbreviations and Acronyms   EF = ejection fraction   ICD = implantable cardioverter-defibrillator   IVCD = intraventricular conduction delay   LBBB = left bundle branch block   NSVT = nonsustained ventricular tachycardia   VT = ventricular tachycardia

Related Article

Risk Assessment for Defibrillator Therapy: Il Trittico

Kelley P. Anderson
J. Am. Coll. Cardiol. 2007 50: 1158-1160. [Full Text] [PDF]

This article has been cited by other articles:

				C. J. W. Borleffs, G. H. van Welsenes, R. J. van Bommel, E. T. van der Velde, J. J. Bax, L. van Erven, H. Putter, J. G. van der Bom, F. R. Rosendaal, and M. J. Schalij Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease Eur. Heart J., November 23, 2009; (2009) ehp497v1. [Abstract] [Full Text] [PDF]

				J. P. Piccini, M. Zhang, K. Pieper, S. D. Solomon, S. M. Al-Khatib, F. Van de Werf, M. A. Pfeffer, J. J.V. McMurray, R. M. Califf, and E. J. Velazquez Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial Eur. Heart J., October 23, 2009; (2009) ehp425v1. [Abstract] [Full Text] [PDF]

				W. C. Levy, K. L. Lee, A. S. Hellkamp, J. E. Poole, D. Mozaffarian, D. T. Linker, A. P. Maggioni, I. Anand, P. A. Poole-Wilson, D. P. Fishbein, et al. Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population Circulation, September 8, 2009; 120(10): 835 - 842. [Abstract] [Full Text] [PDF]

				R. J. Myerburg, V. Reddy, and A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763. [Abstract] [Full Text] [PDF]

				A. E. Epstein Reply. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1163 - 1163. [Full Text] [PDF]

				R. J. Myerburg Implantable Cardioverter-Defibrillators after Myocardial Infarction N. Engl. J. Med., November 20, 2008; 359(21): 2245 - 2253. [Full Text] [PDF]

				D. S. Rosenbaum T-Wave Alternans in the Sudden Cardiac Death in Heart Failure Trial Population: Signal or Noise? Circulation, November 11, 2008; 118(20): 2015 - 2018. [Full Text] [PDF]

				J. P. Piccini, J. R. Horton, L. K. Shaw, S. M. Al-Khatib, K. L. Lee, A. E. Iskandrian, and S. Borges-Neto Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death Circ Cardiovasc Imaging, November 1, 2008; 1(3): 180 - 188. [Abstract] [Full Text] [PDF]

				M. R. de Sousa, C. A. Morillo, F. T. Rabelo, A. M. N. Filho, and A. L.P. Ribeiro Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis Eur J Heart Fail, October 1, 2008; 10(10): 1007 - 1014. [Abstract] [Full Text] [PDF]

				A. E. Epstein Benefits of the Implantable Cardioverter-Defibrillator J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1122 - 1127. [Abstract] [Full Text] [PDF]

				M. M. Scheinman and E. Keung The Year in Review of Clinical Cardiac Electrophysiology J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2075 - 2081. [Full Text] [PDF]

				M. I. Travin A Potential Key Role for Radionuclide Imaging in the Prediction and Prevention of Sudden Arrhythmic Cardiac Death J. Nucl. Med., February 1, 2008; 49(2): 173 - 175. [Full Text] [PDF]

				S. Mittal Selecting Patients for an Implantable Cardioverter-Defibrillator: Can the Genie Be Put Back Into the Bottle? J. Am. Coll. Cardiol., January 22, 2008; 51(3): 297 - 299. [Full Text] [PDF]

				K. P. Anderson Risk Assessment for Defibrillator Therapy: Il Trittico J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1158 - 1160. [Full Text] [PDF]